Mito-FLAG with Ara-C as bolus versus continuous infusion in recurrent or refractory AML--long-term results of a prospective randomized intergroup study of the East German Study Group Hematology/Oncology (OSHO) and the Study Alliance Leukemia (SAL).
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Study Alliance Leukemia (SAL) Johannes Schetelig Martin Bornhäuser Gerhard Ehninger |
| Publication date | April 28, 2015 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |